Absence of adverse effects of tiotropium/ olodaterol compared with the monocomponents on long-term heart rate and blood pressure in patients with moderate-to-very-severe COPD
© 2020 Andreas et al.
2020
2020-09-21 11:33:25
1033
pulmonary disease, chronic obstructive -- drug therapy, heart rate, blood pressure, tiotropium, olodaterol
kronična obstruktivna pljučna bolezen -- terapija z zdravili, srčna frekvenca, krvni tlakt, tiotropij, olodaterol
Dove Medical Press
Stefan
Andreas
70
Lorcan
Mcgarvey
70
Ulrich
Bothner
70
Matthias
Trampisch
70
Alberto
De La Hoz
70
Matjaž
Fležar
70
Roland
Buhl
70
Peter
Alter
70
UDK
4
616.2
ISSN pri članku
9
1178-2005
DOI
15
10.2147/COPD.S246348
COBISS_ID
3
28042755
OceCobissID
13
512411449
RAZ_Andreas_Stefan_i2020.pdf
2979309
Predstavitvena datoteka
2021-05-14 13:41:02
0
Izvorni URL
2020-09-21 11:40:11